| Theodore C Weatherwax, MD | |
|
55 Fruit St, Boston, MA 02114-2621 | |
| (617) 726-3557 | |
| Not Available |
| Full Name | Theodore C Weatherwax |
|---|---|
| Gender | Male |
| Speciality | Family Medicine - Addiction Medicine |
| Location | 55 Fruit St, Boston, Massachusetts |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1144882879 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | MDRE.ML.60958797 (Washington) | Secondary |
| 207QA0401X | Family Medicine - Addiction Medicine | 291350 (Massachusetts) | Primary |
| Entity Name | Massachusetts General Physicians Organization Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1801874573 PECOS PAC ID: 2466365820 Enrollment ID: O20031111000434 |
News Archive
The U.S. Department of Health and Human Services has issued a final rule for Patient Safety Organizations (PSOs).
Mildred Warner, professor of city and regional planning in the College of Architecture, Art and Planning, has secured a $500,000 grant from the U.S. Department of Agriculture to extend her work on multigenerational planning in rural areas.
Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, announced today that it has amended and restated its loan agreement with Silicon Valley Bank that provides for a $32 million working capital revolving line of credit.
Household net worth is a major and overlooked factor in adherence to hormonal therapy among breast cancer patients and partially explains racial disparities in quality of care. The findings suggest that physicians, health insurers, and policy makers need to pay more attention to this economic variable to ensure that breast cancer patients receive this potentially life-saving treatment.
Eli Lilly and Company today announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation to abemaciclib, a cyclin-dependent kinase (CDK) 4 and 6 inhibitor, for patients with refractory hormone-receptor-positive (HR+) advanced or metastatic breast cancer.
› Verified 6 days ago
| Entity Name | The General Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1023049236 PECOS PAC ID: 6507803806 Enrollment ID: O20080313000351 |
News Archive
The U.S. Department of Health and Human Services has issued a final rule for Patient Safety Organizations (PSOs).
Mildred Warner, professor of city and regional planning in the College of Architecture, Art and Planning, has secured a $500,000 grant from the U.S. Department of Agriculture to extend her work on multigenerational planning in rural areas.
Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, announced today that it has amended and restated its loan agreement with Silicon Valley Bank that provides for a $32 million working capital revolving line of credit.
Household net worth is a major and overlooked factor in adherence to hormonal therapy among breast cancer patients and partially explains racial disparities in quality of care. The findings suggest that physicians, health insurers, and policy makers need to pay more attention to this economic variable to ensure that breast cancer patients receive this potentially life-saving treatment.
Eli Lilly and Company today announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation to abemaciclib, a cyclin-dependent kinase (CDK) 4 and 6 inhibitor, for patients with refractory hormone-receptor-positive (HR+) advanced or metastatic breast cancer.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Theodore C Weatherwax, MD 2209 E 32nd St, Tacoma, WA 98404-4922 Ph: (253) 593-0232 | Theodore C Weatherwax, MD 55 Fruit St, Boston, MA 02114-2621 Ph: (617) 726-3557 |
News Archive
The U.S. Department of Health and Human Services has issued a final rule for Patient Safety Organizations (PSOs).
Mildred Warner, professor of city and regional planning in the College of Architecture, Art and Planning, has secured a $500,000 grant from the U.S. Department of Agriculture to extend her work on multigenerational planning in rural areas.
Alphatec Holdings, Inc., the parent company of Alphatec Spine, Inc., a medical device company that designs, develops, manufactures and markets products for the surgical treatment of spine disorders, with a focus on treating conditions related to the aging spine, announced today that it has amended and restated its loan agreement with Silicon Valley Bank that provides for a $32 million working capital revolving line of credit.
Household net worth is a major and overlooked factor in adherence to hormonal therapy among breast cancer patients and partially explains racial disparities in quality of care. The findings suggest that physicians, health insurers, and policy makers need to pay more attention to this economic variable to ensure that breast cancer patients receive this potentially life-saving treatment.
Eli Lilly and Company today announced that the U.S. Food and Drug Administration has granted Breakthrough Therapy Designation to abemaciclib, a cyclin-dependent kinase (CDK) 4 and 6 inhibitor, for patients with refractory hormone-receptor-positive (HR+) advanced or metastatic breast cancer.
› Verified 6 days ago
Lidya H Wlasiuk, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 850 Harrison Ave, Yacc 5, Boston, MA 02118 Phone: 617-414-2080 Fax: 617-414-2090 | |
Brian R Penti, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 850 Harrison Ave, Yacc 4, Boston, MA 02118 Phone: 617-414-2080 Fax: 617-414-2090 | |
Alysia L Green, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 915 Commonwealth Ave Rear, Boston, MA 02215 Phone: 617-358-3400 Fax: 617-358-3710 | |
Shahnaz Rahman, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 820 Harrison Ave, Boston, MA 02118 Phone: 404-259-4008 | |
Dr. Amy Min He, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 637 Washington St, Boston, MA 02124 Phone: 617-825-9660 | |
Katherine A Gergen Barnett, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 11 Melnea Cass Blvd, Boston, MA 02119 Phone: 617-414-2080 Fax: 617-414-2090 | |
Dr. Xiangxin Chen, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 145 South St, Boston, MA 02111 Phone: 617-482-7555 Fax: 617-482-2930 |